Search

everythinglearnresearchcommunity

for

Search:↓

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prolactin affects when mice shed and grow hair.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Prolactin affects when mice shed and grow hair.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

New steroids were effective in blocking male hormone receptors in hamster prostates.